Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 4Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 16Vaginal Neoplasms 3Gliosarcoma 2Glioblastoma 2Endometrial Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Small Cell Lung Carcinoma 1Retinoblastoma 1Prostatic Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adenocarcinoma 1Abdominal Malignancy 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Brachytherapy × Clear all
NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

University of Miami

Phase 1 Completed
8 enrolled
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡